Pharmaceuticals companies across the globe are experiencing a wave of challenges in solving the issues around clinical and operational innovation, voluminous data generation, regulatory compliance, and customer engagement, to name a few. Today, the rise in specialty drugs has complicated both clinical trials and regulatory approvals. Companies in this sector have begun rapid adoption of new technologies such as data analytics that can determine the direction of product development and manage and assess the results of personalized medicine delivery. Thus, companies are constantly revising their business strategy to address multiple challenges and compete in the dynamic pharmaceutical market. Some strategies adopted by companies are in-licensing, outsourcing, reducing the cost of drug discovery, development, manufacturing and sales and marketing. Pharmaceutical companies are outsourcing their manufacturing operations without making any significant capital investment. This allows companies to invest and focus their resources on their core competencies to generate more value.
By leveraging technologies such as data management and analytics, organizations now can turn data into innovative insights accelerating new product development, enabling expansion into new markets, and improving patient outcomes, all while reducing costs and creating a more agile operating model. Developing such an extensive database of clinical information allows researchers to harness a 360-degree view of medical conditions and further shorten the amount of time it takes to diagnose the diseases.
This edition of Pharma Tech Outlook Magazine brings you the “Top 10 Pharma Outsourcing Companies in Europe - 2021.” We present you some of the most prominent organizations in the industry that have excelled with their services and solutions portfolio. This list aims to bridge the gap between businesses and consulting/service providers that are transforming business processes through their insights and technological prowess.
